For the First Time in 20 Years U.S Approves a New Drug for Battling Alzheimer’s

The FDA has approved a new medicine for the Alzheimer’s, the United States making a fundamental development in the battle against the disease, for the first time in nearly 20 years. More than 30 million people around the globe are thought to have the Alzheimer’s, most of them being around 65 years old.

That being said, Aducanumab is the new ray of hope for those who have struggled with the most common form of dementia. The drug is targeting the underlying cause rather than its symptoms, says bbc. com.

Photo by Lightspring via shutterstock.com

A disease with no cure

The disease was first named and discovered by Alois Alzheimer in 1906 and  has left a path of cognitive destruction for its victims ever since it was cataloged, and up until this point in 20 years there were no significant treatments which could have helped in any way the patients. This demanding, but dry market has few made few discoveries among the years such as: donepezil, rivastigmine, galantamine and so on; which can reduce the symptoms and help keep some of them under control.

 

Photo by Atthapon Raksthaput via shutterstock.com

About the medicine

The new wonder  drug was developed by  Biogen and the Japanese pharmaceutical company, Eisai. Aducanumab’s target is amyloid, a protein which is responsible for destroying cells and causing dementia, including: memory and communication issues, thinking complications and high confusion.

It is not yet known how much will the medicine cost, but analysts  have determined the price to go around 50,000 USD a year per patient, while some discuss it to be placed between 2,500 to 8,300 USD per patient a year. The developing companies have denied to make any statements on the pricing matter. What is certain though is that access will be limited to those with a confirmed diagnosis.

 

Photo by BigKhem via shutterstock.com

Controversy

Aducanumab made headlines in 2016 when an early trial showed the first encouraging results of an Alzheimer’s treatment in decades. Previous efforts to develop drugs and vaccines to control the expansion of amyloid protein plaques in the brain were frustrating failures.

The first time Aducanumab was made public was five years ago, when it showed some positive results in the fight against the sickness, which generated a silver lining for those suffering. However, because of some difficulties in 2019 when the subjects of the studies which were administrated the medication did not do better than the placebo given subjects. Despite that, the Japanese and American company have stated the problem with their trials was misreading the data, not the drug itself.

Still, in the present day, some scientists have put under the question mark the actual result of the medicine mainly because the latest trials, which involved over 3,000 people who were given a monthly dose, didn’t make a difference or a significant change on the patients. However, the manufacturer, Biogen, argued that the reason for that was the fact that the dose needs to be given in a higher dose.

There is still a strong divided opinion between the brilliant minds in the world regarding the wonder drug, the Alzheimer’s Society calling the drug ,,promising” adding it is ,,just the beginning of the road to new treatments for Alzheimer’s disease”. That being said, the FDA wants the developer of the drug to run additional placebo studies to verify its effectiveness and make sure it is safe to be placed on the market.

 

Photo by fizkes via shutterstock.com

What’s next

The medicine is set to be approved by the regulatory authorities in the UK, which might take up to one year. Nonetheless, the NGOs and the Alzheimer’s Association are making pressions in order for the process of approval to be faster and put an end for those suffering and their families. Nonetheless this is a huge discovery and an extra step to find a cure for Alzheimer’s, the scientists making fundamental changes not only on the medical domain, but in people’s lives as well.

You might also like: 9 Myths You Might Believe About Alzheimer’s Disease

Facebook
Twitter
WhatsApp
Pinterest
Reddit
LinkedIn
Facebook
Twitter
WhatsApp

Leave a Comment

Your email address will not be published. Required fields are marked *

READ NEXT

8 Reasons Why Your Stomachache Is a Major Concern

A stomachache can knock down your Holiday plans, and, sometimes, the pain doesn’t come from what you eat. However, that doesn’t make stomachaches any less annoying and incredibly uncomfortable. Fortunately,

5 Essential Facts to Know About Sleep Apnea

Obstructive sleep apnea (OSA) is the most common type of sleep apnea, and occurs when the muscles in your throat become blocked (“obstructed”) while you sleep. Another type of sleep

8 Things You Should Sanitize Every Day

With the spread of coronavirus, we are all focused on cleaning our homes as often and as well as possible. So, if you want to stay safe, you have to

10 Hidden Health Dangers You Can’t Ignore

A home invasion is everyone’s worst nightmare. What’s scarier than that: A silent killer hiding inside your body. Lurking inside all of us could be something seriously wrong, a hidden

12 Shocking Things That Are Damaging Your Body

We all know chain-smoking, eating junk food, and drinking a bottle of wine each night are unhealthy habits. But there are other surprising and subtle things you do everyday that

15 Signs You’re Vitamin C Deficient

Vitamins are an important part of someone’s overall health and, without them, our bodies can’t complete essential tasks and functions. Although they are crucial, it appears that approximately 92 percent

10 Tips to Stay Healthy This Holiday Season

    Fast-food burgers Moderation is the key of a healthy life, so grass-fed, high-quality beef may have some heart benefits, according to Dr. Regina Druz, associate professor of cardiology

Scroll to Top